Raphael Pharmaceutical (RAPH) Assets Average (2021 - 2025)
Raphael Pharmaceutical's (RAPH) quarterly Assets Average came in at $30000.0 in Q4 2025, down 23.08% year-on-year from $39000.0 in Q4 2024, and up 62.16% quarter-over-quarter from $18500.0 in Q3 2025.
Raphael Pharmaceutical (RAPH) Assets Average (2021 - 2025) Analysis & Trends
Raphael Pharmaceutical has disclosed Assets Average across 5 years of filings, most recently posting $30000.0 for Q4 2025.
- Assets Average for Q4 2025 came in at $30000.0, down 23.08% year-over-year; the trailing twelve-month figure through Dec 2025 was $30000.0 (down 23.08% YoY), and the FY2025 annual result was $40000.0, down 69.92% from the prior year.
- Assets Average came in at $30000.0 for Q4 2025 at Raphael Pharmaceutical, up from $18500.0 in the prior quarter.
- In the past five years, Assets Average ranged from a high of $321000.0 in Q4 2023 to a low of $18500.0 in Q3 2025.
- The 5-year median for Assets Average is $188000.0 (2022), against an average of $171147.1.
- Peak annual rise in Assets Average reached 78.81% in 2024, while the deepest fall reached 87.85% in 2024.
- Raphael Pharmaceutical's Assets Average stood at $242000.0 in 2021, then decreased by 6.2% to $227000.0 in 2022, then soared by 41.41% to $321000.0 in 2023, then tumbled by 87.85% to $39000.0 in 2024, then declined by 23.08% to $30000.0 in 2025.
- The last three Assets Average figures came in at $30000.0 (Q4 2025), $18500.0 (Q3 2025), and $61500.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 40.39 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 15.32 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 7.30 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 552.96 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 4.77 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 13.29 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 3.37 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 2.21 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.29 Bn |
| 10 | Raphael Pharmaceutical | - | - | - | 30,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 30,000.00 |
| Sep 30, 2025 | 18,500.00 |
| Jun 30, 2025 | 61,500.00 |
| Mar 31, 2025 | 60,000.00 |
| Dec 31, 2024 | 39,000.00 |
| Sep 30, 2024 | 89,500.00 |
| Jun 30, 2024 | 240,500.00 |
| Mar 31, 2024 | 296,000.00 |
| Dec 31, 2023 | 321,000.00 |
| Sep 30, 2023 | 261,000.00 |
| Jun 30, 2023 | 134,500.00 |
| Mar 31, 2023 | 241,500.00 |
| Dec 31, 2022 | 227,000.00 |
| Sep 30, 2022 | 158,500.00 |
| Jun 30, 2022 | 188,000.00 |
| Mar 31, 2022 | 301,000.00 |
| Dec 31, 2021 | 242,000.00 |